PCR 시장(제7판) : qPCR, dPCR, 싱글플렉스 및 멀티플렉스 - 용도별, 제품별, 장소별 예측 - 경영진 및 컨설턴트 가이드와 맞춤형 예측/분석 포함(2025-2029년)

The pandemic drove PCR into a dominant technology role but now new markets and technologies are opening up that will change how diseases are diagnosed. PCR plays a central role. Find out about the opportunities and threats in this new global market.

The report forecasts the market size out five years with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance The two key trends of Point of Care Testing and Molecular Diagnostics are merging but what does that look like? Find out in this comprehensive report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

• 1.1. Situation Analysis
• 1.2. Guide for Executives and Marketing Staff
• 1.3. Guide for Investment Analysts and Management Consultants
• 1.4. Impact of Artificial Intelligence

2. Introduction and Market Definition

• 2.1. What are PCR Technologies?
• 2.2. PCR and Syndromic Testing
• 2.3. Market Definition
  • 2.3.1. Market Size
  • 2.3.2. Currency
  • 2.3.3. Years
• 2.4. Methodology
  • 2.4.1. Methodology
  • 2.4.2. Sources
  • 2.4.3. Authors
• 2.5. Perspective: Healthcare and the IVD Industry
  • 2.5.1. Global Healthcare Spending
  • 2.5.2. Spending on Diagnostics
  • 2.5.3. Important Role of Insurance for Diagnostics

3. PCR - Guide to PCR Technologies

• 3.1. Concepts
  • 3.1.1. Method
• 3.2. Applications
  • 3.2.1. Finding Specific DNA
  • 3.2.2. Measuring DNA
  • 3.2.3. Medical and Diagnostic Applications
    • 3.2.3.1. Carrier, prenatal and tissue typing
    • 3.2.3.2. Cancer Diagnosis and Management
    • 3.2.3.3. Infectious Disease - New Levels of Accuracy and Sensitivity
    • 3.2.3.4. Forensic Applications
    • 3.2.3.5. Science and Research
• 3.3. PCR - Advantages and Disadvantages
• 3.4. Different Types of PCR
  • 3.4.1. Simple Changes
    • 3.4.1.1. Multiplex-PCR
    • 3.4.1.2. VNTR PCR
    • 3.4.1.3. Asymmetric PCR
    • 3.4.1.4. Long PCR
    • 3.4.1.5. Nested PCR
    • 3.4.1.6. Quantitative PCR
    • 3.4.1.7. Hot-start PCR
    • 3.4.1.8. Touchdown PCR
    • 3.4.1.9. Assembly PCR
    • 3.4.1.10. Colony PCR
    • 3.4.1.11. Suicide PCR
    • 3.4.1.12. Cold PCR
  • 3.4.2. Digital PCR
    • 3.4.2.1. Droplet Digital PCR
    • 3.4.2.2. Comparison between dPCR and Real-Time PCR (qPCR)
    • 3.4.2.3. Digital PCR in Use
    • 3.4.2.4. Digital PCR Commercial History
  • 3.4.3. Isothermal PCR

4. Industry Overview

• 4.1. Players in a Dynamic Market
  • 4.1.1. Academic Research Lab
  • 4.1.2. Diagnostic Test Developer
  • 4.1.3. Instrumentation Supplier
  • 4.1.4. Chemical/Reagent Supplier
  • 4.1.5. Pathology Supplier
  • 4.1.6. Independent Clinical Laboratory
  • 4.1.7. Public National/regional Laboratory
  • 4.1.8. Hospital Laboratory
  • 4.1.9. Physicians Office Lab (POLS)
  • 4.1.10. Audit Body
  • 4.1.11. Certification Body

5. Market Trends

• 5.1. Factors Driving Growth
  • 5.1.1. A New Standard
  • 5.1.2. Down the Curve We Go
  • 5.1.3. Multiplexing
  • 5.1.4. Syndromic Diagnostics Looks Unstoppable
  • 5.1.5. The Genetic Blizzard
• 5.2. Factors Limiting Growth
  • 5.2.1. The Cost Curve
  • 5.2.2. The Other Guys
  • 5.2.3. Systemic Roadblocks
• 5.3. Diagnostic Technology Development
  • 5.3.1. The Instrumentation Curve
  • 5.3.2. Shifting Role of Diagnostics
  • 5.3.3. Diagnostics Moves Out of the Hospital
  • 5.3.4. Disruption Looms
  • 5.3.5. The Next Five Years

6. PCR Recent Developments

• 6.1. Recent Developments - Importance and How to Use This Section
  • 6.1.1. Importance of These Developments
  • 6.1.2. How to Use This Section
• 6.2. Bio-Rad to acquire Stilla Technologies
• 6.3. OralDNA Labs Acquires Point-of-Care qPCR Tech
• 6.4. Qiagen, Eli Lilly Collaborate on Alzheimer's Risk Dx Panel
• 6.5. CARB-X Makes Awards to Prompt Diagnostics, Fuse Diagnostics for STI Tests
• 6.6. Qiagen QiAcuity dPCR PanCancer Kits and QiaSeq Targeted RNA-seq Panel
• 6.7. Seegene, Microsoft Collaborate for MDx Development
• 6.8. QuidelOrtho Expanding Savanna Test Menu
• 6.9. Binx Health Refocuses on POC STI Testing
• 6.10. Qiagen, Myriad Genetics Partner to Develop Cancer Dx
• 6.11. VedaBio Detecting Nucleic Acid With CRISPR
• 6.12. Evvy Launches Add-on STI Screen
• 6.13. ChromaCode Shifts to Oncology with dPCR Lung Cancer Test
• 6.14. Multiplex Meningitis/Encephalitis Panel Market Expanding
• 6.15. Sensible Dx to Launch 10-Minute POC PCR System
• 6.16. ReadyGo Dx Plans to Make MDx Testing Easy
• 6.17. Transformative Biotech Acquires Summit Biolabs' PCR Tech
• 6.18. Visby Medical POC STI Multiplex Test Cleared
• 6.19. Sherlock Biosciences Buys Sense Biodetection
• 6.20. Agilent, Qiagen Nab FDA Approvals for Lung Cancer Treatment CDx
• 6.21. HealthTrackRx Investing in Rapid Turnaround Times
• 6.22. LEX Dx Developing Ultra-Fast Low-Cost PCR
• 6.23. Next-Gen Dx Technologies Face Uncertain Future
• 6.24. Rover Dx Developing All-Optical Rapid POC qPCR Platform
• 6.25. ProtonDx Plans Rapid Molecular Dx Instrument
• 6.26. Innova Medical Group Licenses MDx Tech
• 6.27. MicroGEM to Grow Market for 30-Minute RT-PCR System
• 6.28. Precipio Receives CE-IVD Mark for Cancer Panels
• 6.29. Siemens Healthineers to Develop Next-Gen MDx Platform
• 6.30. New York State Approves Enzo Biochem HPV Molecular Test
• 6.31. Grip Molecular Developing Biosensor Panel to Detect Respiratory Infections
• 6.32. Co-Diagnostics Seeks EUA for At-Home PCR Diagnostic System
• 6.33. Chelex-Based Protocol to Reduce Cost, Time for PCR Testing
• 6.34. Finnish Firms to Form Point-of-Care Testing Firm
• 6.35. Visby Medical Scales Up Handheld PCR Test for STIs
• 6.36. DnaNudge Raises $60M
• 6.37. Roche Reports Diagnostics Revenue Up 51 Percent
• 6.38. BforCure Preparing Multiple ID Panels for PoC qPCR Platform
• 6.39. Enzo Biochem, CLX Health Partner for C19 Testing for Travel
• 6.40. Bio Molecular Systems Gets Approval for Portable PCR Cycler
• 6.41. Roche Acquires GenMark
• 6.42. Handheld qPCR Devices Close to Commercialization
• 6.43. Nuclein Closes $14M in Funding
• 6.44. WuXi Diagnostics Closes $150M Series B Financing Round
• 6.45. Visby Medical to develop rapid Flu-COVID PCR test
• 6.46. Thermo Fisher to acquire Mesa Biotech

7. Profiles of Key PCR Companies

• 7.1. Abbott Laboratories
• 7.2. Accelerate Diagnostics
• 7.3. Ador Diagnostics
• 7.4. ADT Biotech
• 7.5. Agilent
• 7.6. Akonni Biosystems
• 7.7. Altona Diagnostics
• 7.8. Alveo Technologies
• 7.9. Amoy Diagnostics Co., Ltd.
• 7.10. Anatolia Geneworks
• 7.11. Applied BioCode
• 7.12. Applied DNA Sciences
• 7.13. Aurora Biomed
• 7.14. Aus Diagnostics
• 7.15. AVIVA Systems Biology
• 7.16. Beckman Coulter Diagnostics (Danaher)
• 7.17. Becton, Dickinson and Company
• 7.18. Binx Health
• 7.19. Biocartis
• 7.20. bioMerieux Diagnostics
• 7.21. Bioneer Corporation
• 7.22. Bio-Rad Laboratories, Inc
• 7.23. Bosch Healthcare Solutions GmbH
• 7.24. Bruker
• 7.25. Caris Molecular Diagnostics
• 7.26. Cepheid (Danaher)
• 7.27. Credo Diagnostics Biomedical
• 7.28. CTK Biotech
• 7.29. Cue Health
• 7.30. Curetis (OpGen)
• 7.31. Diagenode Diagnostics (Hologic)
• 7.32. Diasorin S.p.A.
• 7.33. Eiken Chemical
• 7.34. Enzo Biochem
• 7.35. Eurofins Scientific
• 7.36. Fluxergy
• 7.37. Fujirebio
• 7.38. Genetic Signatures
• 7.39. GenMark Dx (Roche)
• 7.40. Greiner Bio-One
• 7.41. Hologic
• 7.42. Immunexpress
• 7.43. Inflammatix
• 7.44. Invetech
• 7.45. J&J Innovative Medicine
• 7.46. Karius
• 7.47. LumiraDx
• 7.48. Maxim Biomedical
• 7.49. Meridian Bioscience
• 7.50. Millipore Sigma
• 7.51. Molbio Diagnostics
• 7.52. Nanomix
• 7.53. NGeneBio
• 7.54. Novacyt
• 7.55. Nuclein
• 7.56. Operon
• 7.57. Panagene
• 7.58. Precipio
• 7.59. Primerdesign (Novacyt)
• 7.60. Promega
• 7.61. Prominex
• 7.62. Qiagen
• 7.63. QuantuMDx
• 7.64. QuidelOrtho
• 7.65. Randox Toxicology
• 7.66. R-Biopharm AG
• 7.67. Revvity
• 7.68. Roche Diagnostics
• 7.69. Scope Fluidics
• 7.70. SD Biosensor
• 7.71. Seegene
• 7.72. Siemens Healthineers
• 7.73. SkylineDx
• 7.74. Sona Nanotech
• 7.75. SpeeDx
• 7.76. Standard BioTools
• 7.77. Stilla Technologies
• 7.78. Streamline Scientific
• 7.79. T2 Biosystems
• 7.80. Thermo Fisher Scientific
• 7.81. Uniogen
• 7.82. Vela Diagnostics
• 7.83. Veramarx
• 7.84. Veredus Laboratories
• 7.85. Vircell
• 7.86. Visby Medical
• 7.87. XCR Diagnostics
• 7.88. YD Diagnostics
• 7.89. Zhejiang Orient Gene Biotech

8. The Global PCR Markets

• 8.1. PCR - Global Market Overview by Country
  • 8.1.1. Table - Global Market by Country
  • 8.1.2. Chart - Global Market by Country
• 8.2. Global Market by Application - Overview
  • 8.2.1. Table - Global Market by Application
  • 8.2.2. Chart - Global Market by Application - Segments Growth
  • 8.2.3. Chart - Global Market by Application - Base/Final Comparison
  • 8.2.4. Chart - Global Market by Application - Base Year
  • 8.2.5. Chart - Global Market by Application - Final Year
  • 8.2.6. Chart - Global Market by Application - Share by Year
• 8.3. Global Market by Technology - Overview
  • 8.3.1. Table - Global Market by Technology
  • 8.3.2. Chart - Global Market by Technology - Segments Growth
  • 8.3.3. Chart - Global Market by Technology - Base/Final Comparison
  • 8.3.4. Chart - Global Market by Technology - Base Year
  • 8.3.5. Chart - Global Market by Technology - Final Year
  • 8.3.6. Chart - Global Market by Technology - Share by Year
• 8.4. Global Market by Product - Overview
  • 8.4.1. Table - Global Market by Product
  • 8.4.2. Chart - Global Market by Product - Segments Growth
  • 8.4.3. Chart - Global Market by Product - Base/Final Comparison
  • 8.4.4. Chart - Global Market by Product - Base Year
  • 8.4.5. Chart - Global Market by Product - Final Year
  • 8.4.6. Chart - Global Market by Product - Share by Year
• 8.5. Global Market by Place - Overview
  • 8.5.1. Table - Global Market by Place
  • 8.5.2. Chart - Global Market by Place - Segments Growth
  • 8.5.3. Chart - Global Market by Place - Base/Final Comparison
  • 8.5.4. Chart - Global Market by Place - Base Year
  • 8.5.5. Chart - Global Market by Place - Final Year
  • 8.5.6. Chart - Global Market by Place - Share by Year

9. Global PCR Markets - By Application

• 9.1. PCR Clinical Multiplex
  • 9.1.1. Table PCR Clinical Multiplex Testing - by Country
  • 9.1.2. Chart - PCR Clinical Multiplex Testing Growth
• 9.2. PCR Clinical Singleplex
  • 9.2.1. Table PCR Clinical Singleplex Testing - by Country
  • 9.2.2. Chart - PCR Clinical Singleplex Testing Growth
• 9.3. PCR Research
  • 9.3.1. Table PCR Research - by Country
  • 9.3.2. Chart - PCR Research Growth
• 9.4. PCR Other Application
  • 9.4.1. Table PCR Other Application - by Country
  • 9.4.2. Chart - Other Application Growth

10. Global PCR Markets - By Technology

• 10.1. qPCR
  • 10.1.1. Table qPCR - by Country
  • 10.1.2. Chart - qPCR Growth
• 10.2. dPCR
  • 10.2.1. Table dPCR - by Country
  • 10.2.2. Chart - dPCR Growth
• 10.3. Other Technology
  • 10.3.1. Table Other Technology - by Country
  • 10.3.2. Chart - Other Technology Growth

11. Global PCR Markets - By Product

• 11.1. PCR Instruments
  • 11.1.1. Table PCR Instruments - by Country
  • 11.1.2. Chart - PCR Instruments Growth
• 11.2. PCR Nucleic Acid Extraction
  • 11.2.1. Table PCR Nucleic Acid Extraction - by Country
  • 11.2.2. Chart - PCR Nucleic Acid Extraction Growth
• 11.3. PCR Consumables
  • 11.3.1. Table PCR Consumables - by Country
  • 11.3.2. Chart - PCR Consumables Growth
• 11.4. PCR Services
  • 11.4.1. Table Services - by Country
  • 11.4.2. Chart - PCR Services Growth

12. Global PCR Markets - By Place

• 12.1. PCR Clinical Laboratory
  • 12.1.1. Table PCR Clinical Clinical Laboratory - by Country
  • 12.1.2. Chart - PCR Clinical Clinical Laboratory Growth
• 12.2. PCR Point of Care
  • 12.2.1. Table PCR Point of Care - by Country
  • 12.2.2. Chart - PCR Point of Care Growth
• 12.3. PCR Commercial
  • 12.3.1. Table PCR Commercial - by Country
  • 12.3.2. Chart - PCR Commercial Growth
• 12.4. PCR Pharmaceutical
  • 12.4.1. Table PCR Pharmaceutical - by Country
  • 12.4.2. Chart - PCR Pharmaceutical Growth
• 12.5. PCR Other Place
  • 12.5.1. Table PCR Other Place - by Country
  • 12.5.2. Chart - PCR Other Place Growth

13. Appendices

• 13.1. Growth of Approved IVD Test Menu
• 13.2. Growth of Approved Average IVD Test Fee
• 13.3. The Most Used IVD Assays
• 13.4. The Highest Grossing Assays
• 13.5. Laboratory Fees Schedule